![]() |
Volumn 37, Issue SUPPL. 71, 2008, Pages 3-29
|
2nd European Consensus Meeting on Foam Sclerotherapy 2006 Tegernsee, Germany
a
NONE
(Germany)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBON DIOXIDE;
LOW MOLECULAR WEIGHT HEPARIN;
OXYGEN;
POLIDOCANOL;
SCLEROSING AGENT;
TETRADECYL SULFATE SODIUM;
ANAMNESIS;
BODY POSITION;
CLINICAL EFFECTIVENESS;
COMPRESSION;
CONCENTRATION (PARAMETERS);
CONFERENCE PAPER;
CONSENSUS;
DRUG SAFETY;
ECHOGRAPHY;
EXPERT SYSTEM;
FOAM;
FOAM SCLEROTHERAPY;
FOOT;
GAS;
HEALTH CARE ACCESS;
HIGH RISK PATIENT;
HUMAN;
ISCHEMIA;
LEG COMPRESSION;
LEG MOVEMENT;
LIQUID;
MIGRAINE WITH AURA;
NEUROLOGICAL COMPLICATION;
NON INVASIVE PROCEDURE;
PATENT FORAMEN OVALE;
PATIENT INFORMATION;
PATIENT SAFETY;
QUESTIONNAIRE;
RISK BENEFIT ANALYSIS;
SCLEROTHERAPY;
SCREENING;
TELANGIECTASIA;
THERAPY EFFECT;
THROMBOEMBOLISM;
THROMBOPHILIA;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
VALSALVA MANEUVER;
VARICOSIS;
VASOSPASM;
VEIN CATHETERIZATION;
VEIN DIAMETER;
VEIN MALFORMATION;
VEIN PUNCTURE;
VISCOSITY;
VISUAL DISORDER;
|
EID: 40349113272
PISSN: 03011526
EISSN: None
Source Type: Journal
DOI: 10.1024/0301-1526.37.S71.3 Document Type: Conference Paper |
Times cited : (139)
|
References (65)
|